Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Myoinositol--a uremic neurotoxin?

A Blumberg, E Esslen, W Bürgi

    Nephron
    |January 1, 1978
    PubMed
    Summary
    This summary is machine-generated.

    Elevated myo-inositol levels in predialysis patients did not correlate with neurological disturbances, suggesting it is not a direct cause of uremic neuropathy despite being retained during renal insufficiency.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    A Peculiar Case of Irritation of the Nervous System, in a Child Whilst Teething.

    The Dental register·2021
    Same author

    Multidrug-resistant tuberculosis patients' views of interventions to reduce treatment loss to follow-up.

    The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease·2017
    Same author

    [Drug safety: challenge in an aging society].

    Der Nervenarzt·2014
    Same author

    The association of the Guillain-Barré syndrome with infectious mononucleosis; with a report of two fatal cases.

    Blood·2010
    Same author

    Moderate physical exercise: a simplified approach for ventricular rate control in older patients with atrial fibrillation.

    Clinical research in cardiology : official journal of the German Cardiac Society·2008
    Same author

    Effects of glucocorticoid immunosuppression on serum cystatin C concentrations in renal transplant patients.

    Clinical chemistry·2001
    Same journal

    The Impact of High-Altitude Acclimatization on Frontal Lobe Executive Function: The Mediating Effect of Creatinine.

    Nephron·2026
    Same journal

    Expert Commentary of the Recent International Pediatric Nephrology Association IgA Vasculitis Nephritis Guidelines.

    Nephron·2026
    Same journal

    Acute effects of exercise on the nephron index under different conditions in middle-aged males - a preliminary study.

    Nephron·2026
    Same journal

    Lysozyme-Associated Nephropathy in Myeloid Neoplasms: A Clinicopathological and Mass Spectrometric Study of Two Cases.

    Nephron·2026
    Same journal

    Prevalence of COVID-19 Pneumonia and Clinical Characteristics in Hemodialysis Patients During the SARS-CoV-2 Omicron Pandemic.

    Nephron·2026
    Same journal

    Real-World Outcomes of Patients with Monoclonal Gammopathy of Renal Significance.

    Nephron·2026
    See all related articles

    Area of Science:

    • Biochemistry
    • Nephrology
    • Neuroscience

    Background:

    • Myo-inositol is a substance retained in patients with renal insufficiency.
    • Elevated myo-inositol levels are observed in predialysis patients.

    Purpose of the Study:

    • To investigate the relationship between plasma and spinal fluid myo-inositol levels and neurological disturbances in patients with renal insufficiency.
    • To determine if myo-inositol contributes to uremic neurological complications.

    Main Methods:

    • Measured plasma and spinal fluid myo-inositol concentrations in predialysis patients and compared them to normal controls.
    • Assessed nerve conduction velocities and electroencephalogram (EEG) tracings in patients.
    • Analyzed correlations between myo-inositol levels and neurological parameters.

    Related Experiment Videos

    Main Results:

    • Predialysis plasma myo-inositol was significantly elevated in patients compared to normals and decreased after dialysis.
    • Spinal fluid myo-inositol was also increased in patients.
    • No significant correlation was found between myo-inositol levels (plasma or spinal fluid) and reduced nerve conduction velocities or abnormal EEG findings.

    Conclusions:

    • While myo-inositol is retained in renal insufficiency, the study found no evidence that it acts as a toxin causing uremic neurological disturbances.
    • Further research may be needed to fully elucidate the role of retained substances in uremic neuropathy.